Results 121 to 130 of about 10,619,315 (293)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau +11 more
wiley +1 more source
Universal composable threshold signature
, 2009 Threshold signature allowed any subset of t parties generating a signature,but that disallowed the creation of a valid signature if fewer than t parties participate in the protocol.Since the security of threshold signature was only con-sidered in a ...
HONG Xuan1, CHEN Ke-fei2, LI Qiang2
core
NeuroImage: ClinicalDevelopmental dyslexia (DD) is a heritable neurodevelopmental disorder associated with altered brain connectivity. The influence of genetic risks on cortico-cerebellar effective connectivity (EC) remains unclear.
Gökçe Korkmaz +9 more
doaj +1 more source
Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS‐CoV‐2 infection (Neuro‐PASC) between females and males. Methods Cross‐sectional study of the first consecutive 261 posthospitalization Neuro‐PASC (PNP) and 2068 nonhospitalized Neuro‐PASC (NNP) patients evaluated at the Neuro‐COVID clinic between ...
Hannah Kopinsky +5 more
wiley +1 more source
Group-Oriented Digital Signature and envelop with Java Card Implementation
, 2007 隨著科技的發展，電子簽章與電子信封在現今的電子商務中越發重要。一個組織持有一組 密鑰/公鑰 來代表這個組織的情況也越來越普遍。對於這種情況，群體導向門檻理論提供了便利而安全的方法來產生群體簽章或是破解密文。任何群體以外的人可以傳送一份以這個群體公鑰加密過的文件給這個群體，而只要參與解密的群體成員人數大於或是等於門檻限制，就可以正確解密這份密文。 群體簽章的方面，只要參與簽章的群體成員人數大於或是等於門檻人數，就能夠產生有效的群體簽章，而任何群體以外的人都可以簡單的驗證這份簽章的有效性。在這份論文裡 ...
張靜雯, Chang, Chin-Wen
core
Frontiers in ImmunologyBackgroundCurrent guidelines to treat atopic dermatitis (AD) overlook disease heterogeneity, limiting personalized care. This study assessed NuGel, a topical GPCR19 agonist, for efficacy, safety, and predictive baseline biomarkers in AD patients ...
Gyeong Ho Baek +23 more
doaj +1 more source
Deep Learning Pose Estimation for Phenotyping of Co‐Occurring Hyperkinetic Movement Disorders
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To explore whether routine outpatient video combined with deep learning‐based pose estimation and clinically interpretable kinematic features can support multi‐label phenotyping of co‐occurring hyperkinetic movement disorders (HMDs).
Laura Cif +17 more
wiley +1 more source
Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias +3 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Treatment of disorders of consciousness (DoC) remains a major clinical challenge, and noninvasive, targeted modulation of deep brain structures has emerged as a promising therapeutic strategy. We aimed to evaluate the feasibility/safety and preliminary effects of thalamic temporal interference stimulation (TIS) targeting centromedian‐
Gengyao Hu +7 more
wiley +1 more source
Global Rather Than Vertical‐Selective Saccadic Abnormalities in Progressive Supranuclear Palsy
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To test whether vertical saccades are preferentially affected in Progressive Supranuclear Palsy (PSP). Methods PSP patients (n = 24) were compared to age‐matched controls (n = 94) and two degenerative groups (Alzheimer's disease, n = 20; Lewy body disease, n = 50).
Duy Duan Nguyen +6 more
wiley +1 more source